Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users

BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. AIM: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by mean...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ghirardi, Arianna, Scotti, Lorenza, Zambon, Antonella, Della Vedova, Gianluca, Cavalieri D'oro, Luca, Lapi, Francesco, Cipriani, Francesco, Caputi, Achille P., Vaccheri, Alberto, Gregori, Dario, Gesuita, Rosaria, Vestri, Annarita, Staniscia, Tommaso, Mazzaglia, Giampiero, Corrao, Giovanni
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2013
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3857168/
https://ncbi.nlm.nih.gov/pubmed/24348985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0073159
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы